Bayer Aktiengesellschaft (FRA:BAYN)
Germany · Delayed Price · Currency is EUR 38.96
-0.48 (-1.20%)
At close: Jan 9, 2026
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
€518,248
Profits / Employee
€2,237
Market Cap
38.20B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Dec 31, 2021 | 95,950 | -5 | -0.01% |
| Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Bayer Aktiengesellschaft News
- 2 days ago - Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress - Nasdaq
- 3 days ago - Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy - Wallstreet:Online
- 3 days ago - Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy - Business Wire
- 4 days ago - Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization - Benzinga
- 5 days ago - Bayer sues COVID vaccine makers over mRNA technology - Reuters
- 5 days ago - Pesticide industry ‘immunity shield’ stripped from US appropriations bill - The Guardian
- 5 days ago - Bayer-Krebsmittel Sevabertinib in USA und China mit Breakthrough-Therapy-Status - Finanz Nachrichten
- 6 days ago - Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan's 44th Annual Healthcare Conference - Business Wire